Pelthos Therapeutics Inc.
Company Information
Industry
Biological Products, (No Diagnostic Substances)
SIC Code
2836
Entity Type
operating
SEC Category
Emerging growth company
State of Incorporation
NV
Business Address
4020 STIRRUP CREEK DRIVE, DURHAM, NC, 27703
Mailing Address
4020 STIRRUP CREEK DRIVE, DURHAM, NC, 27703
Phone
919-908-2422
Fiscal Year End
1231
EIN
863335449
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4/A Insider transaction amendment | April 1, 2026 | View on SEC |
| 4/A Insider transaction amendment | April 1, 2026 | View on SEC |
| 4/A Insider transaction amendment | April 1, 2026 | View on SEC |
| 4/A Insider transaction amendment | April 1, 2026 | View on SEC |
| 4/A Insider transaction amendment | April 1, 2026 | View on SEC |
| 4/A Insider transaction amendment | April 1, 2026 | View on SEC |
| 4/A Insider transaction amendment | April 1, 2026 | View on SEC |
| 4/A Insider transaction amendment | April 1, 2026 | View on SEC |
| 4/A Insider transaction amendment | April 1, 2026 | View on SEC |
| 8-K Current report of material events | March 19, 2026 | View on SEC |
Annual Reports
10-K
March 19, 2026
- Successfully completed IPO in February 2024, becoming a public company and securing significant capital.
- Rapidly expanded its dermatology product line through strategic acquisitions, including Xepi and XEGLYZE assets.
Material Events
8-K
Strategy Change
January 12, 2026
Low Impact
- Pelthos adjusted director compensation to align with peer group standards.
- The changes aim to attract and retain highly skilled and engaged non-employee directors.
8-K
Acquisition
January 2, 2026
High Impact
- Pelthos Therapeutics Inc. acquired Xeglyze, a head lice treatment, and all related assets from Hatchtech Pty Ltd.
- The acquisition includes all rights, patents, trademarks, technical knowledge, regulatory approvals, inventory, and equipment for Xeglyze.
Related Companies
Companies in the same industry (SIC: 2836)
Cardiff Oncology, Inc.
CRDF
Biological Products, (No Diagnostic Substances)
Voyager Therapeutics, Inc.
VYGR
Biological Products, (No Diagnostic Substances)
HALOZYME THERAPEUTICS, INC.
HALO
Biological Products, (No Diagnostic Substances)
Immunovant, Inc.
IMVT
Biological Products, (No Diagnostic Substances)
Adaptive Biotechnologies Corp
ADPT
Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.